Bourdow Carrie L.

Director at Nabriva Therapeutics AG

Sold, on record
$2k
Dollars the filings state
Form 4 sales
2
Latest Aug 1, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Nabriva Therapeutics AGPlan not stated
    Aug 2, 2021 2021

    Sold 777 shares at $1.20 ($932)

    Bourdow Carrie L., Director

    Sold 4% of holdings ($23k position)18,473 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Nabriva Therapeutics AGUnusual
    Aug 1, 2022 +364 days

    Sold 8,540 shares at $0.17 ($1k)

    Bourdow Carrie L., Director

    Sold 46.2% of holdings ($3k position)9,933 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Bourdow Carrie L.
Source
Aug 1, 2022Aug 3, 2022Nabriva Therapeutics AGDirectorForm 4 sale8,540$1k46.2%UnusualSEC
Aug 2, 2021Aug 4, 2021Nabriva Therapeutics AGDirectorForm 4 sale777$9324.0%Plan not statedSEC